Agoracom Blog Home

Posts Tagged ‘Hemp’

Spyder #Cannabis $SPDR.ca – #CBD-based Functional Drinks Charm Health Conscious Consumers $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:29 PM on Tuesday, July 16th, 2019

SPONSOR: Spyder Cannabis Inc. (TSX-V: SPDR) An established chain of high-end vape stores in Ontario, Canada. The company has an aggressive expansion plan already in place that will focus on Canadian retail and US Hemp-Derived kiosks in high traffic areas. Click here for more info.

Spdr logo large
(TSX-V: SPDR)
————————

CBD-based Functional Drinks Charm Health Conscious Consumers

  • Cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers
  • Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products

NEW YORK, July 16, 2019 — Each year, more and more countries are moving towards approving cannabis use. In particular, medicinal cannabis is witnessing immense support as most of the countries looking to enter into the market space are more keen on the medical sector due to the therapeutic benefits associated with cannabis. However, several regions around the world have also either decriminalized or legalized the use of recreational cannabis in moderate amounts. For instance, Canada completely legalized adult-use cannabis in late 2018. On the other hand, countries such as Colombia and Spain have only decriminalized recreational use, allowing adults to possess up to a certain amount.

Moreover, the U.S. has given states the jurisdiction to legalize cannabis or keep the drug illicit. As a result, more than half the U.S. legalized cannabis for medical use, while a fifth of the nation, including the District of Columbia, allows for legal recreational usage. While the medical marketplace is much more globally prevalent, the recreational market is expected to overshadow the medical segment as the North American market continues to mature.

Additionally, as the recreational market continues to expand, consumers are also experiencing an influx of new products. Aside from traditional cannabis flower, consumers can now choose from a variety of products at dispensaries and retail stores. Now, cannabis-based concentrates, extracts, and edibles are becoming highly popular among consumers. Specifically, the edible and beverage marketplace is quickly gaining popularity due to the ease at which customers can use the products.

Furthermore, a large recreational user base exists for the edible and beverage market, and the industry is heavily being accelerated by the increasing demand for wellness products to treat a variety of health concerns. According to data compiled by Reports and Data, the global cannabis-based beverage market was valued at USD 1.57 Billion in 2018. By 2026, the market is expected to reach USD 5.04 Billion while exhibiting a CAGR of 15.4% during the forecast period.

The cannabis-infused edible and beverage market is expected to witness a strong increase in demand, particularly for beverages over the next several years. Canaccord Genuity analyst Bobby Burleson noted last year that beverages packed with CBD or THC ingredients can account for nearly 20% of the U.S. edible products markets by 2022, increasing from 6% in 2018. Burleson highlighted that the growing beverage industry is becoming an attractive investment opportunity for beer and soda makers and that data has shown that there is a direct correlation between alcohol and cannabis consumption.

A joint research conducted by the University of Connecticut, Georgia State University, and Universidad Del Pacifico discovered that counties located in medical marijuana states witnessed a 15% reduction in monthly alcohol sales. The conclusion of the study uncovered that cannabis and alcohol are both substitutes for one another, meaning that they share the same target audience. The study also indicates that as more countries move towards cannabis legalization, more users will be inclined to shift over to the cannabis market. The shift has even prompted alcohol producers to enter into the cannabis industry to maximize its consumer base reach.

While alcohol beverage producers may look towards developing THC beverages, soda producers are looking to leverage CBD for health and wellness beverages. Soda producers are specifically focusing on CBD because of the consumer shifts from sugary drinks to more functional options. Regardless of the market type, Canaccord expects both the THC and CBD-based beverage markets in the U.S. to experience growth, as by 2022, Canaccord expects the demand for CBD beverages to reach USD 260 Million, while THC beverages are projected to reach USD 34 Million. “Interest has spiked from the beer industry on mounting evidence of a substitution relationship between cannabis and alcohol, while large soda companies increasingly view CBD as a natural fit within their strategically important wellness offerings,” Burleson wrote.

Read More: https://www.prnewswire.com/news-releases/cbd-based-functional-drinks-charm-health-conscious-consumers-300885358.html

North Bud Farms Inc. $NBUD.ca – The Week In Cannabis: #Jay-Z Joins #Caliva, #Congress Holds #Marijuana Hearings, #CannTrust Gets Smoked, And More $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:22 PM on Monday, July 15th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

The Week In Cannabis: Jay-Z Joins Caliva, Congress Holds Marijuana Hearings, CannTrust Gets Smoked, And More

Javier Hasse

  • Beyoncé’s husband Jay-Z entered the cannabis industry this week, announcing he’d be joining the California brand Caliva as chief brand strategist.
  • “Jay-Z entering the cannabis space reaffirms that effective brands will drive the future of the cannabis industry.

We applaud his efforts to be a part of the solution in righting the disproportionate impact that the war on drugs has had on minority communities. Jay personifies the perfect mix of celebrity, entrepreneur and true brand,” said Kraig Fox, CEO of High Times, which first reported the news. 

On the policy front, Hawaii decriminalized the possession of small amounts of marijuana, and the U.S. Congress held a landmark hearing regarding cannabis legalization and the need to reform. Here’s what legalization advocates had to say. In addition, the FDA said it was “expediting its work to address the many questions about cannabidiol (CBD),” and Rep. Alexandria Ocasio-Cortez (D-NY) and Sen. Kamala Harris (D-CA) introduced bills in Congress that seek to ensure that people with low-level drug convictions are still able to access public housing, reported Kyle Jaeger on Marijuana Moment.

We also saw a new ETF debut on the NYSE this week. The Cannabis ETF (NYSE: THCX) launched by Innovation Shares claims to be the only pure-play cannabis ETF, with no exposure to tobacco or alcohol.

The fund has lower fees than its NYSE peers and differentiates itself from others on the back of its monthly rebalancing strategy, versus a more standard quarterly rebalancing approach, fund adviser Jon Najarian told Benzinga. 

CannTrust Holdings Inc (NYSE: CTST) got smoked after Health Canada discovered one of its facilities was non-compliant with regulations. Later in the week, it was reported that illicitly produced cannabis had been not only sold in Canada but also exported to Denmark.

“420 Investor” Alan Brochstein told Benzinga he thinks CEO Peter Aceto should apologize for violating Health Canada rules and resign.

Debra Borchardt, CEO of Green Market Report, said the CannTrust scandal shows that public cannabis companies can’t always be trusted to do the right thing. 

“This company grew plants in an unlicensed room and figured they’d get away with it, which is a sign of incredibly poor judgment since this is such a highly regulated industry. They also admitted to storage problems at another facility and have since stopped sales,” she said. 

The poor decision-making by company leaders hurts patients and shareholders alike, Borchardt said.

“Hiring a quality control officer after the fact just shows this company did too little too late.”

We invite you to check out our story of the week: “From Coffee To Cannabis: Colombian Legislators To Move For Adult-Use Legalization.”

Source: https://finance.yahoo.com/news/week-cannabis-jay-z-joins-190322597.html

CLIENT FEATURE: Spyder Cannabis $SPDR.ca An Established Chain of High-End #Vape Stores With Aggressive Expansion Plans $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:11 PM on Monday, July 15th, 2019

WHY SPYDER CANNABIS?

  • Developed a scalable retail model with aggressive expansion plan to create a significant retail footprint and establishing strategic partners as a top priority
  • Targeted and disciplined retail distribution strategy focusing on high quality, high traffic peripheral areas
  • Focused strategy aimed at vertical, horizontal and geographic diversification with demonstrated operations expertise and proven retail roll-out
  • Opened two additional stores in July for a total of 5 locations

Retail Locations

The Lundys Lane Location, two other retail locations that Spyder operates in Burlington and Calgary and a location that it intends to open in Guelph, subject to negotiating satisfactory terms with the landlord, will all be converted into cannabis retail stores as part of the Company’s “Cannabis Turn-Key Strategy”.

Under phase one of the Turn-Key Strategy

  • Spyder intends to operate a number of retail locations that will, in contrast to a number of its competitors, generate revenue by operating as retailers of a variety of non-cannabis products.

Under phase two of the Turn-Key Strategy

  • Spyder will, subject to the receipt of cannabis retail licences from the Alcohol and Gaming Commission of Ontario and the Alberta Gaming, Liquor and Cannabis Commission, convert these retailers into cannabis stores at the earliest possible opportunity.
  • The Company believes this strategy will allow it to generate stable revenue streams during the interim period before the stores receive a retail cannabis licence, and will allow the Company to swiftly pivot into the sale of cannabis products once appropriate licences have been received.

The Opportunity

Established Product Portfolio

 Hemp-Derived Market Opportunity

Retail Layout

FULL DISCLOSURE: Spyder Cannabis is an advertising client of AGORA Internet Relations Corp.

Bougainville Ventures $BOG.ca Hires Processing Company to Process the First 1,700 lbs of Hemp $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 7:53 AM on Thursday, July 11th, 2019
681747 5720 copy 2
  • Announced that it has hired a mobile processing company to travel to Portland Oregon from Washington State to process last year’s hemp crop.
  • The total amount to be processed is approximately 1,700 lbs of bio-mass and should take about 5 days to process. The anticipated the value of the crop is $250,000 USD.

VANCOUVER, British Columbia, July 11, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE: BOG) (8BV-FF:Frankfurt Stock Exchange) – The Company is pleased to announce that it has hired a mobile processing company to travel to Portland Oregon from Washington State to process last year’s hemp crop. The total amount to be processed is approximately 1,700 lbs of bio-mass and should take about 5 days to process. The anticipated the value of the crop is $250,000 USD.

Andy Jagpal, President Comments:

“This is a great day and milestone reached by our company. Not only have we completed on our LOI with Worm Casting, and planted a successful second crop for 2019, but we are in the midst of reporting revenue this year by processing last year’s crop. The estimated value is expected to be $250,000 USD and could be reported as early as the 4th quarter of 2019. To be reporting revenue only after a year of trading is quit the accomplishment for a junior company. Also, the relationship we have established with the mobile processing company will also be able to process this year’s harvest as well.”

Please visit the link below to view a video of the Oregon Hemp Farm:

About Mobile Processor
The extraction company has a mobile extraction laboratory and extractor to service the cannabis sector. The type of services which can be performed on these mobile platforms include: dehydration of plant material, cannabis grinding, solvent-based extraction and filtration, fractional distillation, and odor elimination.

About Bougainville Ventures, Inc.Bougainville Ventures Inc. is dedicated to rapid growth in production, processing, retail and branding of cannabis and cannabis related products. Currently the company provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Also, the Company is focused on building a strong presence in the hemp industry with the objective of extracting cannabinoids in both Canada and the United States. Along with our flagship Hemp project in Oregon State and the Greenhouse campus in Washington state, the Company has proprietary formulas for cannabis edibles, topical, and tinctures.

On behalf of the Board of Directors 
BOUGAINVILLE VENTURES INC.

Andy Jagpal, President and Director

For further information, please contact Andy Jagpal at [email protected]. Please note that our Toll free number has changed to 1-877-517-7816.

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

North Bud Farms Inc. $NBUD.ca – Consumer Entry into the #Cannabis Market Spikes Post Legalization $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:35 PM on Tuesday, July 9th, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

NBUD: CSE

—————

Consumer Entry into the Cannabis Market Spikes Post Legalization

  • Global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025.

NEW YORK, July 9, 2019 — Within the first quarter of legalization, 5.3 million or 18% of Canadian ages 15 years and older reported using cannabis, according to Statistics Canada. Following legalization, a large number of new users were willing to try cannabis solely because it was legalized and readily accessible. However, a year prior to legalization, only around 14% of Canadians reported using the plant. During the quarter, approximately 646,000 of the users reported trying cannabis for the first time, rising dramatically when compared to 327,000 users a year prior. Overall, the rise year-over-year is largely due to the abundance of male users between the ages of 45 to 64.

Generally, within that age group, adults tend to use cannabis for medical purposes, largely due to medical conditions associated with aging. For instance, cases such as chronic pain, Alzheimer’s, and Parkinson’s are typically associated with the older generation. And through extensive studies, researchers have discovered that cannabis can be used to treat these and several other medical conditions. Furthermore, based on gender, a more significant amount of males used cannabis when compared to females and it was estimated that 22.3% of Canadian males used cannabis compared to only 12.7% of females.

Now, while the large increase in users is largely attributable to the older generation, cannabis is also much more prevalent among the younger generation. Statistics Canada reported that 29.5% of Canadians ages 15 to 24 years old used cannabis in the first quarter. Similarly, approximately 28.7% of Canadians ages 25 to 34-year-olds also used cannabis during the quarter.

While the adoption of cannabis grew among Canadians, it is important to remember that the market is still maturing. And despite its legalization, there are still many legal barriers imposed on the market, restricting the growth of businesses. Nonetheless, the market is projected to continually grow throughout the shortcoming years, developing into a global industry leader. And according to data compiled by Verified Market Research, the global marijuana market was valued at USD 42.20 Billion in 2016. By 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025.

Source: https://www.prnewswire.co.uk/news-releases/consumer-entry-into-the-cannabis-market-spikes-post-legalization-897625196.html

Bougainville Ventures Inc $BOG.ca – Canada’s #cannabis supply issues are real, despite feds’ denial, says business professor $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 11:27 AM on Monday, July 8th, 2019
SPONSOR:  Bougainville Ventures Inc (CSE: BOG) Converting irrigated farmland to greenhouse-equipped farmland. Bougainville does not “touch the plant” and only provides agricultural infrastructure as a landlord for licensed marijuana growers. Click here for more info.
BOG:CSE
—————————————

Canada’s cannabis supply issues are real, despite feds’ denial, says business professor

  • A Canadian business professor says Bill Blair, Minister of Border Security and Organized Crime Reduction, was simply wrong when he said Canada’s cannabis supply shortage was “non-existent.”

By Alexandra Mazur

A Canadian business professor says Bill Blair, Minister of Border Security and Organized Crime Reduction, was simply wrong when he said Canada’s cannabis supply shortage was “non-existent.”

On Wednesday, Rod Phillips, Ontario’s minister of finance, and Doug Downey, Ontario’s attorney general, criticized a federal cannabis supply shortage when announcing Ontario will be licensing 50 new cannabis retail locations across Ontario.

Blair shot back, saying Ontario was “making excuses” and using a “non-existent supply shortage,” for their slow success in subverting the illegal cannabis market in the province.

Blair pointed to Health Canada data that showed in April alone, Canada’s overall cannabis inventory was 24 times more than total sales that month.

But Michael Armstrong, a professor at the Goodman School of Business at Brock University, said the federal government is using seemingly impressive data to skirt around the fact that there are still significant supply issues in Canada.

“They are wildly incorrect to say there’s no cannabis shortage and that there’s enough legal cannabis for those who want it,” Armstrong said in an email.

Canada’s cannabis supply

Armstrong says the majority of Canada’s cannabis inventory, more than 85 per cent of it, is unfinished — that means raw cannabis product that has not been processed, packaged and made ready to sell.

Health Canada data shows that the majority of Canada’s cannabis supply is not ready to sell. Health Canada

Some of that inventory may also never be ready to sell.

“Some of it, unfortunately, may not be sellable, whether that’s contamination or microbial risk or pesticides or anything of that nature,” said John Fowler, president of Supreme Cannabis and vice-chair of the Cannabis Council of Canada, a cannabis business association. “The law does not allow licensed producers to sell that product but it also doesn’t require them to immediately destroy it.”

Armstrong also criticized Blair and Health Canada for equating sales of legal cannabis with national demand.

“Sales isn’t the relevant measure of demand here, because legal sales satisfy just a fraction of total consumption; most is met by black markets,” Armstrong says.

Legal marijuana retailers are competing with illegal dealers, Armstrong says, so to use legal sales as a benchmark for demand in Canada is wrong.

“No one really knows how big the black market is and how much total consumption there is,” Armstrong said.

Nevertheless, he has estimated, using Health Canada data from a report they commissioned on estimated cannabis use in the fall, overall demand of dried cannabis, including illegal and medical sales, would land somewhere around 56,000 kilograms a month.

Health Canada has been tracking cannabis sales since legalization on their website. Numbers for April show dried cannabis sales reached just below 9,000 kilograms, leaving just over 13,000 kilograms inventory available to sell.

WATCH: Industry experts: Education on cannabis edibles needed

If Armstrong’s numbers are correct, this would leave a 43,000 kilogram gap that may have been filled by illegal sales.

“They’re looking at sales as their consumption. Businesses often do that — they look at ‘are we keeping up with sales,’ but they’re doing that when they have a healthy industry where sales is almost equal to demand,” Armstrong said.

Blair’s team said Health Canada is holding up their end of the bargain when it comes to licensing producers.

As of March 31, 2019, Health Canada says federally licensed cultivators are reporting nearly 700,000 square metres of land under active cultivation, which can produce 1 million kilograms of cannabis per year.

“This is roughly equivalent to estimates of the total quantity of cannabis (legal and illegal) consumed in Canada, made by independent market analysts, the Parliamentary Budget Officer and federal government departments,” said Marie-Emmanuelle Cadieux, senior communications advisor for Blair.

But Armstrong maintains that the numbers show the industry is continuing to have trouble meeting demand.

Getting cannabis on the shelves 

In the past, Health Canada has acknowledged that Canada’s supply issues don’t lie with the creation of the product, but rather with the production process itself.

What exactly is wrong with production is a bit of a mystery, Armstrong said. Whether it’s that producers are not growing high enough volumes of quality cannabis that can turn into dry cannabis, or they don’t have production facilities, or there are still issues with shipping, Armstrong said he can only speculate.

“Big inventories are not translating into shipments going out the door,” Armstrong said.

Armstrong said that issues with federally mandated labelling could have also slowed things down. He also guessed that certain producers focused on getting greenhouses ready for marketing purpose rather than setting up a production line that could handle orders coming in from huge markets like the Ontario Cannabis Store.

John Fowler, is chalking production issues up to growing pains of a new market.

“I think, overall, things have been working pretty well,” said Fowler. “Perhaps there was a lack of understanding of the complexity, not just regulatory complexity of license approvals, but just building the businesses and the supply chains to go from a market that literally didn’t exist on October 17th.”

Fowler said at this point, every part of the industry is being stretched. It’s taking time to get licenses for smaller growers, as well as licenses to expand growing spaces, and packaging and equipment manufacturers are also being weighed down by a huge surge in demand.

“It’s one of those things it’s not one issue that’s holding the industry back from meeting its growth objectives.”

When it comes to whether it’s a smart strategy to limit the amount of cannabis stores in Ontario because of a production issue, Armstrong says Ontario may be shooting themselves in the foot, considering provinces like Alberta and British Columbia will have booming markets with retailers ready to receive the inventory when it’s ready to sell.

But he says, they aren’t wrong in their reasoning for doing so.

“When they say that there’s not enough supply and there’s massive shortages, absolutely, that is correct.”

In the end, Fowler doesn’t believe these delays, whether to overall supply or to Ontario’s cannabis stores, will mean much to an industry that’s meant to last.

“I think cannabis stores hopefully are going to be here for the next 100 years in this province. So a little bit of a six-month delay in launch to be better for the next ninety-nine-and-a-half years. You know, I don’t think it is a bad decision.”

The Minister of Finance did not respond to a request for comment for this story.

Source: https://globalnews.ca/news/5463653/canadas-cannabis-supply-feds-denial/

Empower Clinics $CBDT.ca Commences Selling Franchises Under The Sun Valley Health Brand $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 7:16 AM on Monday, July 8th, 2019
Epw logo1
  • Company’s clinic division, Sun Valley Health, has completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States

VANCOUVER, July 8, 2019 - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, is pleased to announce that the Company’s clinic division, Sun Valley Health, has completed it’s 2019 Franchise Disclosure Document (FDD) and has commenced selling Sun Valley Health franchises in the United States. Learn more at http://www.sunvalleyhealth.com

With the completion of the 2019 Franchise Disclosure Document (FDD) the Company is now selling Sun Valley Health franchises and is accepting franchise applications effectively immediately.

The Company has invested in the development of a new franchise trade show booth that showcases the Sun Valley Health opportunity to perspective franchisees using dynamic, content rich displays and four (4) large format television monitors to present features and benefits to the audience who attend the expos.

The franchise sales teams are booked to participate in the International Franchise Expo https://www.ifeinfo.com and the Cannabis Industry Marketplace Expo www.cannabisimp.com with nine (9) expos booked to showcase the Sun Valley Health franchise opportunity.

Expo Dates

Missouri          July 23-24th 2019 (Cannabis Expo)
Chicago           Sept. 13th-14th 2019 (Franchise Expo)
Chicago           Sept. 19th-20th 2019 (Cannabis Expo)
Houston           Oct. 4th-5th 2019 (Franchise Expo)
Florida             Nov. 13th-14th 2019 (Cannabis Expo)
Long Beach     Dec. 5th-6th 2019 (Franchise Expo)
Arizona            Feb. 12th-13th 2020 (Cannabis Expo)
Miami               Feb. 20th-22nd 2019 (Franchise Expo)
Michigan         April: 15th-17th 2020 (Cannabis Expo)

“Offering our years of experience in operating clinics to potential franchise partners across America is an exceptional growth opportunity for our Company, said Steven McAuley, CEO of Empower Clinics Inc. “We have the opportunity to connect to exponentially more patients who can benefit from direct access to physicians that provide consultations on alternative treatment options.”

The upcoming expos are expected to generate significant interest in the Sun Valley Health brand and it will allow the Company’s franchise sales teams to communicate the benefits and opportunities the industry can offer entrepreneurs, medical professionals and consumers in general.

The Company clinics offer consultations on the potential benefits of CBD based treatment options to address a variety of qualifying conditions including chronic pain, anxiety, PTSD, insomnia, indigestion and other serious aliments that can affect the lives of so many people. The Company also has commenced building retail product kiosks in all clinics offering more than 40 products SKU’s that patients can purchase in-clinic or online. All Sun Valley Health franchises will include similar retail product kiosks that offer Sun Valley Health approved products options.

“Our scientific approach to alternative medicine offers franchisees & patients across America access to quality CBD, MMJ cards, nutritional supplements, and holistic modalities with Physicians and medical professionals on hand and available in our clinics.” said Dustin Klein, Empowers SVP, Business Development and Director.

Each Company owned clinic and all franchised clinics in our nationwide network will offer a full range of CBD products and health & wellness supplements, that provide a wide array of choices to patients and customers in the communities we serve.

ABOUT EMPOWER

Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. Operating as a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company can produce and package its proprietary line of cannabidiol (CBD) based products and distribute through company owned and franchised clinics, with wholesale partnerships, online and with retailers nationwide.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; access to Empower’s home delivery and e-commerce platform; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operation by Q2 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2019/08/c3952.html

Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019

Spyder #Cannabis $SPDR.ca Looks To Create Value For Investors With Its Unique Retail Strategy $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 9:48 PM on Wednesday, July 3rd, 2019
  • The cannabis retail market represents a massive opportunity and it is much less saturated when compared to the cannabis cultivation opportunity
  • The company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar

By Anthony Varrell

During the last year, the amount of interest in the legal cannabis industry has significantly increased and most of this attention has been focused on North America. This is a trend that we have been excited about as it has benefited the companies that are levered to the burgeoning cannabis market.

Earlier this month, we came across a cannabis business that is focused on the North American cannabis retail opportunity. The cannabis retail market represents a massive opportunity and it is much less saturated when compared to the cannabis cultivation opportunity. The company, Spyder Cannabis (SPDR: TSX Venture) recently completed a go-public transaction and has been flying under the radar.

Spyder Cannabis is an emerging opportunity that is focused on expanding into legal cannabis and hemp industry. The company has developed a scalable retail model that includes an aggressive expansion plan that is focused on creating a significant retail footprint while being highly focused on securing strategic partners.

Spyder Cannabis will utilize a targeting retail distribution strategy and will focus on the cannabis retail opportunity in Canada and the US. The company plans to open retail outlets in high-traffic locations and we are favorable on this approach.

Spyder Cannabis: An Execution Story to be Watching

One of the reasons we are excited about Spyder Cannabis is due to the focus on the cannabis opportunity in the US and Canada. These two markets represent massive opportunities for the company and we are bullish on the growth prospects associated with these markets. Spyder Cannabis will be utilizing a specific strategy to capitalize on each market and we find this to be significant. There are massive differences between the Canadian and the US cannabis market which has made the opportunity for Spyder even more significant.

An attractive aspect of Spyder Cannabis’ expansion plan is related to its plans to partner with a variety of developers to sign lease agreements for prime real estate in close proximity to senior living, sporting venues and malls throughout the US. The company plans to initially focus on the opportunity in California, Florida, Michigan and New York, and we will monitor how the team is able to open new retail outlets and increase market share in the US.

When a company is looking to open a cannabis retail operation, there are countless factors that must be considered. We believe that Spyder Cannabis has the right approach to opening locations and will monitor how the team is able to execute on its expansion strategy. By targeting the aging, athletics and health and wellness community, the company should be able to de-risk its expansion plan and we find this to be significant aspect of the story

Spyder Cannabis is developing a proprietary product line of hemp-derived ointments, oils, capsules and topical creams for the aging, sports and health and wellness space. The products will be sold directly to consumers through both kiosks and retail stores throughout the US. We are favorable on the markets the company is focused on and the strategy to reach consumers. Over the next year, we expect the US market to be a major value driver to Spyder Cannabis and this is an opportunity that we will continue to monitor.

A US Cannabis Retail Expansion Story

When looking at Spyder Cannabis’ approach to capitalizing on the US cannabis market, the first thing to stand out are the states that the company is focused on. Currently, Spyder is executing on an expansion in California, Florida, Michigan, and New York. These are four of the most exciting markets in the US and we are favorable on the growth prospects associated with these markets.

Spyder Cannabis is focused on opening branded boutique retail stores and kiosks in burgeoning cannabis markets in the US. The company has been working tirelessly on this expansion and has been successfully increasing market share in the states that it has entered. Over the next year, we expect to see the company build upon its existing footprint and are favorable on the value that can be created through this expansion.

By 2020, Spyder Cannabis plans to open between 30 to 50 boutique retail stores and kiosks and has developed a cost-effective strategy in order to execute on this. The company is focused on opening locations that require a limited amount of capital expenditures that are in secondary and tertiary markets and located in high-traffics areas. Specifically, Spyder Cannabis plans to open stores that are located close to malls, retirement centers, and sporting events.

A Canadian Expansion Story

When it comes to the Canadian cannabis opportunity, Spyder Cannabis has been executing on a nationwide expansion and already has three operational Spyder Vape stores open in Ontario. Over the next year, the company plans to significant increase its reach in Canada and plans to open 20 retail locations in Ontario, 5 retail locations in Alberta, and 5 retail locations in British Columbia.

Currently, there are two additional Spyder Vape stores under construction in Ontario and we will monitor how the management team is able to execute on this expansion. The company has been granted a development permit for a retail location in Alberta and we are favorable on the growth prospects associated with this market.

When it comes to the cannabis retail opportunity in Ontario, Spyder Cannabis is strategically positioning itself throughout the province through the opening of Spyder Vape stores. Once the company has received the necessary permits, it plans to convert these outlets to cannabis retail locations and we are favorable on the strategy in place.

Alberta represents a different type opportunity when it comes to the cannabis retail market. Currently, there is a cannabis supply shortage and the province has put a hold on issuing retail licenses. This has caused a steep decline in the price of development permits and Spyder Cannabis has been focused on acquiring permits for high-traffic locations.

An Industry Leader in the Making

Spyder Cannabis wants to become the most recognizable brand of independent retail stores and kiosks throughout North America. The company is focused on offering best-in-class cannabis products and tailored retail experiences in order to attract consumers and we are favorable on this approach. Spyder Cannabis has strategic partnership with more than 30 premium cannabis vendors and offers an industry leading portfolio of cannabis products.

One of the reasons we are bullish on Spyder Cannabis is due to the way that the management has positioned the business. The company is led by an executive team that has a proven track record of success and that has positioned the business to capitalize on the North American cannabis market. We are favorable on the growth prospects associated with the planned expansion and will monitor how the company continues to expand across North America.

We are favorable on the strategic relationships that Spyder Cannabis has been able to secure and find this to be an attractive aspect of the story. From real estate partners to cannabis brand partners, the company has done a fantastic job at pooling together its relationships to support all facets of the business. Spyder Cannabis will be leveraging its contacts for increased brand awareness and cross-selling opportunities. We are favorable on this strategy when it comes to becoming a leading cannabis brand and will be monitoring how the team executes on this.

Spyder Cannabis is a company that has significant potential catalysts for growth and this is an opportunity that we are excited about. To learn more about the North American cannabis company, please reach out to [email protected].

Pursuant to an agreement between StoneBridge Partners LLC and Spyder Cannabis we have been hired for a period of 30 days beginning June 11, 2019 and ending July 11, 2019 to publicly disseminate information about (SPDR) including on the Website and other media including Facebook and Twitter. We are being paid $6,750 per month (SPDR) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero (0) shares of (SPDR), which we purchased in the open market. We plan to sell the “ZERO” shares of (SPDR) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (SPDR) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

Source: https://technical420.com/cannabis-article/spyder-cannabis-looks-to-create-value-for-investors-with-its-unique-retail-strategy/#

CLIENT FEATURE: NORTHBUD $NBUD.ca – Canada on Verge of CA$2.7 Billion Infused #Cannabis Market $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 2:49 PM on Tuesday, July 2nd, 2019

WHY NORTHBUD FARMS?

  • Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
    As shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
  • Infused products sector has become the highest margin segment of the industry
  • Positioned to be a raw input producer for this space
  • Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products

RECENT HIGHLIGHTS

North Bud Farms Signs Binding Letter of Intent to Acquire Nevada Botanical Science

  • Transaction valued at USD$7 million
  • Medical and adult use licenses for cultivation extraction and distribution.
  • NBS currently operates a 5,000 sq. ft. indoor cultivation facility and have been approved for expansion of up to 100,000 sq. ft.
  • Located in Reno, Nevada

North Bud Farms Signs Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor

  • Transaction valued at CAD$20 million
  • In 2018, Eureka recognized revenue of approximately CAD$11.5 million*
    • net profit margin of 16%* from its California and Colorado operations
  • Anticipates further growth in revenue due to anticipated changes to retail regulation of adult cannabis use in California.

Justin Braune, CEO of Eureka Vapor, joins Scott to share the company’s background and why Eureka was an ideal match for North Bud. Watch until the end to hear Justin’s predictions on Federal de-regulation in the US.

FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.

Marijuana Company of America $MCOA Provides Update on Viva Buds, Its #Cannabis Delivery Service $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:32 AM on Tuesday, July 2nd, 2019
15233 mcoa
  • Announced that the Company’s manufacturing and distribution facility for its Viva Buds cannabis delivery service is expected to be completed and fully functional by August 2019.
  • Announced in April that it had acquired a 20% ownership interest in Natural Plant Extract of California to establish a joint venture to create Viva Buds Inc., a unique cannabis delivery service based in Los Angeles, California.

ESCONDIDO, Calif., July 02, 2019 – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced that the Company’s manufacturing and distribution facility for its Viva Buds cannabis delivery service is expected to be completed and fully functional by August 2019.

MCOA announced in April that it had acquired a 20% ownership interest in Natural Plant Extract of California (“NPE”) to establish a joint venture to create Viva Buds Inc., a unique cannabis delivery service based in Los Angeles, California.

“We are making tremendous progress through our partnership with NPE and the rollout of our licensed cannabis manufacturing facility,” said Mr. Edward Manolos, Board Member of MCOA. “Our commitment to compliance will put Viva Buds ahead of the competition in California at a time when many license holders are still awaiting permits. Such permits are difficult to attain for manufacturers currently using volatile extraction methodologies, due to stringent regulations on California’s Manufactured Cannabis Safety.”

“Our joint venture partnership with NPE will allow us to become more competitive within the bourgeoning cannabis industry in Southern California,” said Mr. Don Steinberg, CEO of MCOA. “Once completed and launched, Viva Buds will offer consumers a line of high-quality products at low prices along with the ability to build their own personal cannabis business.”

The Lynwood, California manufacturing facility is licensed for the volatile manufacturing, distribution and retail delivery of cannabis products. NPE’s volatile manufacturing process is an efficient and cost-effective extraction process that will help distinguish NPE from others that use extraction.

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Natural Plant Extracts of California
NPE is a fully licensed cannabis manufacturing, distribution and non-store front retail delivery. The Company has secured its licenses with the state of California and city of Lynwood, CA. For more information about the Company, please visit its website at https://nldistribution.com

The owners and founders of NPE are marijuana industry veterans with decades of experience in establishing retail, manufacturing and distribution of cannabis in California, including obtaining the first retail dispensary licenses in Los Angeles, CA.

Legal Status of Cannabis
While legalized in California for recreational and medicinal use, cannabis remains a Schedule 1 drug under the Controlled Substances Act (21 U.S.C. § 811) and illegal under the federal law.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, “intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:
[email protected]
888-777-4362

Corporate Communications Contact: 
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com 
212.418.1217 Office 
[email protected] 

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA